Holen Sie sich die Stockscreener-App
18.81
0.32%
0.06
Handel nachbörslich:
18.62
-0.19
-1.01%
Schlusskurs vom Vortag:
$18.75
Offen:
$18.83
24-Stunden-Volumen:
1.57M
Relative Volume:
0.56
Marktkapitalisierung:
$2.19B
Einnahmen:
$631.73M
Nettoeinkommen (Verlust:
$-239.78M
KGV:
-9.3119
EPS:
-2.02
Netto-Cashflow:
$-33.45M
1W Leistung:
+2.56%
1M Leistung:
+41.00%
6M Leistung:
+112.30%
1J Leistung:
+21.51%
1-Tages-Spanne:
$18.43
$19.29
1-Wochen-Bereich:
$18.12
$20.34
52-Wochen-Spanne:
$6.78
$20.34
10 X Genomics Inc Stock (TXG) Company Profile
Firmenname
10 X Genomics Inc
Sektor
Branche
Telefon
(925) 401-7300
Adresse
6230 STONERIDGE MALL ROAD, PLEASANTON, CA
Vergleichen Sie TXG mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TXG
10 X Genomics Inc
|
18.81 | 2.37B | 631.73M | -239.78M | -33.45M | -2.02 |
|
VEEV
Veeva Systems Inc
|
240.29 | 39.56B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
77.93 | 13.74B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
105.18 | 9.05B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
51.44 | 9.60B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
36.91 | 7.09B | 906.14M | -52.62M | 89.62M | -0.3621 |
10 X Genomics Inc Stock (TXG) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-11 | Eingeleitet | Piper Sandler | Neutral |
| 2025-02-13 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-09-03 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-22 | Hochstufung | Jefferies | Hold → Buy |
| 2024-07-18 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-07-10 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2024-06-27 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-06-25 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-06-03 | Fortgesetzt | Jefferies | Hold |
| 2024-05-01 | Herabstufung | TD Cowen | Buy → Hold |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-10 | Eingeleitet | Barclays | Overweight |
| 2023-03-31 | Eingeleitet | Stephens | Overweight |
| 2023-02-02 | Eingeleitet | UBS | Neutral |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-08-18 | Herabstufung | Goldman | Neutral → Sell |
| 2022-07-25 | Eingeleitet | Canaccord Genuity | Buy |
| 2022-07-15 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-15 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-09-14 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-03-15 | Eingeleitet | William Blair | Outperform |
| 2020-12-02 | Eingeleitet | Goldman | Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-10 | Eingeleitet | Stifel | Buy |
| 2020-03-05 | Eingeleitet | Guggenheim | Buy |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-10-07 | Eingeleitet | BofA/Merrill | Buy |
| 2019-10-07 | Eingeleitet | Cowen | Outperform |
| 2019-10-07 | Eingeleitet | JP Morgan | Overweight |
| 2019-09-24 | Eingeleitet | Evercore ISI | Outperform |
Alle ansehen
10 X Genomics Inc Aktie (TXG) Neueste Nachrichten
What sentiment indicators say about 10x Genomics Inc. stockQuarterly Profit Summary & Reliable Breakout Forecasts - BỘ NỘI VỤ
10x Genomics to Acquire Scale Biosciences (PR Newswire) - Aktiellt
Buy Signal: Is 10x Genomics Inc. stock safe for conservative investorsWeekly Earnings Recap & Reliable Momentum Entry Alerts - BỘ NỘI VỤ
How 10x Genomics Inc. stock responds to policy changes2025 Volatility Report & Risk Managed Trade Strategies - BỘ NỘI VỤ
[Form 4] 10x Genomics, Inc. Insider Trading Activity - Stock Titan
BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know - Finviz
CEO Saxonov Files To Sell 13,096 Of 10X Genomics Inc [TXG] - TradingView
Q3 2025 10X Genomics Inc Earnings Call Transcript - GuruFocus
10x Genomics, Inc. (NASDAQ:TXG) Q4 2024 Earnings Call Transcript - MSN
10x Genomics, Inc.Common Stock (NQ: TXG - Markets Financial Content
Bruker, 10x Genomics, PacBio, ICU Medical, and Dentsply Sirona Shares Skyrocket, What You Need To Know - Yahoo Finance
10X Genomics stock hits 52-week high at 17.7 USD By Investing.com - Investing.com India
10X Genomics stock hits 52-week high at 17.7 USD - Investing.com
Spatial Biology Market Analysis and Forecast, 2025-2035: - GlobeNewswire
Spatial Biology Market Analysis and Forecast, 2025-2035: Stellaromics, RareCyte, and 10x Genomics Drive Innovation and Funding Momentum - Yahoo Finance
How 10x Genomics Inc. (1KJ) stock trades pre earnings2025 Support & Resistance & Reliable Breakout Forecasts - newser.com
Total liabilities & shareholders' equities of 10x Genomics Inc Class A – HAM:1KJ - TradingView
Is 10x Genomics Inc. stock a buy before product launchesJuly 2025 Closing Moves & Safe Entry Zone Tips - newser.com
New ASTRA Consortium Unites Asia-Pacific Scientists to Build Pan-Cancer Spatial Atlas Powered by 10x Genomics' Xenium - StreetInsider
10x Genomics (TXG) Price Target Increased by 10.47% to 16.66 - Nasdaq
10x Genomics Expands Flex Lineup with High-Throughput Single-Cell Assay Launch - MSN
TXG (10x Genomics) Inventory-to-Revenue : 0.44 (As of Sep. 2025) - GuruFocus
10x Genomics Announces Chief Legal Officer Retirement - The Globe and Mail
10x Genomics GC Who Led Rule Of Law Effort To Retire In '26 - Law360
There's Reason For Concern Over 10x Genomics, Inc.'s (NASDAQ:TXG) Massive 42% Price Jump - simplywall.st
10x Genomics, Inc. Announces Executive Changes, Effective January 1, 2026 - MarketScreener
10X Genomics Stock Soars 17.31%, Hits Intraday High of $15.26 - Markets Mojo
10x Genomics Inc Class A Earnings and Revenue – HAM:1KJ - TradingView
How 10x Genomics Inc. (1KJ) stock valuation compares with sectorChart Signals & Safe Entry Point Alerts - newser.com
Why 10x Genomics Inc. (1KJ) stock attracts wealthy investorsSell Signal & Verified Stock Trade Ideas - newser.com
10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025 - Eastern Progress
[8-K] 10x Genomics, Inc. Reports Material Event | TXG SEC FilingForm 8-K - Stock Titan
10x Genomics, Inc. (TXG) Stock Price Quote Today & Current Price Chart - Capital.com
10x Genomics (TXG): Assessing Valuation After Strong Earnings, Upbeat Forecast and New Product Launch - Yahoo Finance
Piper Sandler Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq
10x Genomics to Participate in the Wolfe Research Healthcare Con - GuruFocus
10x Genomics (TXG) Soars to New Record High on Lower Net Loss, Revenue Beat - Insider Monkey
Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance
Is 10x Genomics Inc. stock ready for a breakoutWeekly Market Summary & AI Enhanced Trading Signals - newser.com
Can a trend reversal in 10x Genomics Inc. lead to recovery2025 Volume Leaders & Real-Time Volume Analysis - newser.com
10x Genomics stock hits 52-week high at 17.26 USD - Investing.com
10x Genomics, Inc.'s (NASDAQ:TXG) 33% Price Boost Is Out Of Tune With Revenues - 富途牛牛
Research Alert: CFRA Keeps Hold Rating On Shares Of 10x Genomics, Inc. - 富途牛牛
10X Genomics Tops Q3 Estimates And Cuts Losses - Finimize
Analysts Offer Insights on Healthcare Companies: 10x Genomics (TXG), Eledon Pharmaceuticals (ELDN) and AMN Healthcare Services (AMN) - The Globe and Mail
10x Genomics (TXG): How Fresh Results and New Guidance Are Shaping Its Valuation - simplywall.st
10x Genomics, Inc. (NASDAQ:TXG) Q3 2025 Earnings Call Transcript - Insider Monkey
Canaccord Genuity Maintains 10x Genomics (TXG) Buy Recommendation - Nasdaq
JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq
TXG: Canaccord Genuity Raises Price Target for 10x Genomics to $19 | TXG Stock News - GuruFocus
Finanzdaten der 10 X Genomics Inc-Aktie (TXG)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.28%
2.61%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):